These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37170412)

  • 1. Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients.
    Cazorla JM; Villanego F; Aguilera A; Garcia T; Orellana C; Trujillo T; Gómez AM; Mazuecos A
    Transplantation; 2023 Jul; 107(7):e188-e189. PubMed ID: 37170412
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
    López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
    Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral Response After 5 Successive Doses of COVID-19 Vaccine in Kidney Transplant Patients: Comment.
    Cazorla JM; Villanego F; Aguilera A; Garcia T; Orellana C; Trujillo T; Gómez AM; Mazuecos A
    Transplantation; 2023 Nov; 107(11):e319. PubMed ID: 37870884
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.
    Mungmunpuntipantip R; Wiwanitkit V
    Exp Clin Transplant; 2022 Nov; 20(11):1048. PubMed ID: 36524892
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating?
    Åsberg A; Hovd M; Kjellevold SA; Stenehjem AE; Wien TN; Broch LU; Reier-Nielsen M; Qvale TH; Marti HP; Heldal K; Bitter J; Hagelsteen Kvien E; Vaage JT; Lund-Johansen F; Midtvedt K
    Transplantation; 2023 Oct; 107(10):e279-e280. PubMed ID: 37496122
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Int J Urol; 2022 Nov; 29(11):1279-1286. PubMed ID: 35863901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Humoral Response in Kidney Transplant Recipients and Donors and Healthy Volunteers Following Second Dose of SARS-CoV-2 mRNA Vaccine.
    Sasaki H; Hasegawa K; Harada H; Takamoto D; Takada Y; Hirano T; Tanabe T; Tanaka H; Miura M
    Transplant Proc; 2023 Apr; 55(3):514-520. PubMed ID: 36948961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of two-dose SARS-CoV-2 vaccination
    Chen CC; Huang YJ; Lai MJ; Lin MH; Lin WC; Lin HY; Lin YC; Huang YT; Lee YF; Tsai MK; Lee CY
    Front Immunol; 2022; 13():951576. PubMed ID: 36189313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.
    Reischig T; Kacer M; Vlas T; Drenko P; Kielberger L; Machova J; Topolcan O; Kucera R; Kormunda S
    Am J Transplant; 2022 Mar; 22(3):801-812. PubMed ID: 34860470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients.
    Simone S; Pesce F; Fontò G; Pronzo V; Pontrelli P; Conserva F; Schirinzi A; Casanova A; Gallo P; Rossini M; Lucarelli G; Spilotros M; Rendina M; Stallone G; Di Serio F; Di Leo A; Tafuri S; Ditonno P; Gesualdo L
    J Nephrol; 2023 Jul; 36(6):1663-1671. PubMed ID: 37458909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.
    Grupper A; Rabinowich L; Ben-Yehoyada M; Katchman E; Baruch R; Freund T; Hagin D; Shlomo SB; Schwartz D; Schwartz IF; Shashar M; Bassat OK; Halperin T; Turner D; Saiag E; Goykhman Y; Shibolet O; Levy S; Houri I; Katchman H
    Transplant Proc; 2022; 54(6):1439-1445. PubMed ID: 35346486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.
    Grupper A; Katchman E; Ben-Yehoyada M; Rabinowich L; Schwartz D; Schwartz IF; Shashar M; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
    Clin Transplant; 2021 Dec; 35(12):e14478. PubMed ID: 34506644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
    Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral Response After 5 Successive Doses of COVID-19 Vaccine in Kidney Transplant Patients: Comment.
    Kleebayoon A; Wiwanitkit V
    Transplantation; 2023 Nov; 107(11):e318. PubMed ID: 37870883
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients.
    Nishida H; Takai S; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Tsuchiya N
    Clin Transplant; 2023 May; 37(5):e14952. PubMed ID: 36846878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.